LENT Score Calculator – Malignant Pleural Effusion Survival Prediction

Clinical calculation support · Verify results before clinical use

LENT Score Calculator

Enter the patient's findings at presentation with malignant pleural effusion.

—Total score
L

Pleural Fluid Lactate Dehydrogenase (LDH)

Use pleural fluid LDH in IU/L.

0–1 point

<1500 IU/L = 0 point; ≥1500 IU/L = 1 point.

E

ECOG Performance Status

Select the patient's ECOG performance status.

0–3 points
N

Neutrophil-to-Lymphocyte Ratio (NLR)

Use the peripheral blood (serum/blood-derived) NLR.

0–1 point

<9 = 0 point; ≥9 = 1 point.

T

Tumour Type

Select the primary tumour category used in the original LENT score.

0–2 points
—LENT score
Prognostic risk category
Complete all fields
The prognostic estimate will appear when all four components are entered.

This score estimates prognosis at presentation with malignant pleural effusion; it does not provide an individualized survival prediction.

About the LENT Score

The LENT score is a prognostic tool developed for patients presenting with malignant pleural effusion (MPE). It combines pleural fluid lactate dehydrogenase (LDH), ECOG performance status, neutrophil-to-lymphocyte ratio (NLR), and tumour type.

Scoring Criteria

VariableCriterionPoints
Pleural fluid LDH<1500 / ≥1500 IU/L0 / 1
ECOG PS0 / 1 / 2 / 3–40 / 1 / 2 / 3
Blood NLR<9 / ≥90 / 1
Tumour typeLower / Moderate / Higher risk group0 / 1 / 2

Prognostic Groups

ScoreRisk groupMedian survival (original cohort)
0–1Low319 days (IQR 228–549)
2–4Moderate130 days (IQR 47–467)
5–7High44 days (IQR 22–77)

Clinical Use

Use the score as an adjunct to clinical assessment and shared decision-making. Consider the patient's overall condition, cancer subtype and stage, available anticancer treatment, comorbidities, goals of care, and subsequent clinical course.

References

Clive AO, Kahan BC, Hooper CE, et al.Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score. Thorax. 2014;69(12):1098–1104. DOI: 10.1136/thoraxjnl-2014-205285.
Koegelenberg CFN, Shaw JA, Irusen EM, Lee YCG.Contemporary best practice in the management of malignant pleural effusion. Ther Adv Respir Dis. 2018. DOI: 10.1177/1753466618785098.
ERS/EACTS statement on the management of malignant pleural effusions.European Respiratory Journal. 2018;52:1800349. Official publication.

Important Notes

  • The score was developed for prognostic stratification at presentation with MPE.
  • Median survival values describe the original study cohorts, not an individual patient's expected lifespan.
  • Patients with incomplete or unavailable components should not be assigned an assumed score.
Clinical disclaimer: The LENT score is a prognostic stratification instrument and must not be used as the sole basis for treatment decisions or to determine an individual patient's life expectancy. Interpret results in the context of current clinical assessment, tumour-specific factors, treatment options, and patient preferences.